INTRODUCTION
Magnesium (Mg) is the fourth most plentiful mineral in the body, having
the role of cofactor for enzymatic reactions (1-3). The normal range of
Mg concertation of serum in humans is 1.8-2.3 (4). Magnesium sulfate is
the drug of choice for the prevention and treatment, and recurrence
management of convulsions in eclampsia and pre-eclampsia and it is an
FDA-approved indication in hypomagnesemia management (5-7). Considering
the elevated use of Mg in the management of different conditions, the
safety of therapy needs more research. However, electrocardiographic
(ECG) and electrophysiological outcomes of intravenous (IV) Mg injection
have been assessed in animal research (8). We report a case of Mg
Sulfate toxicity managed with hemodialysis, with clinical improvement
and hospital discharge.